title: Insulin, sodium-lithium countertransport, and microalbuminuria in hypertensive patients.
abstract: Both microalbuminuria (>0.290 nmol/min [20 microg/min]) and high sodium-lithium countertransport (SLC) in diabetic or hypertensive humans are predictive of overt nephropathy and more aggressive cardiovascular complications, perhaps induced by insulin resistance. To analyze the relationships between microalbuminuria, SLC, microalbuminuria, and insulin in essential hypertension, we studied 90 hypertensive white patients, 25 of whom had microalbuminuria and 32 of whom were healthy. When urine sampling was completed for albuminuria determination, SLC was measured; all patients then underwent standard (75 g) oral glucose load to measure basal (0 minutes) and 2-hour glucose and insulin serum levels. Glucose-insulin ratio was used as insulin sensitivity index (ISI). In both hypertensive patients with normal microalbuminuria and those with pathological microalbuminuria, plasma insulin at 120 minutes was significantly higher than in control subjects. When the patients with pathological microalbuminuria were divided into thirds on the basis of their microalbuminuria, in the lower third, we found statistically significant less fasting insulin and higher basal ISI. SLC was higher in hypertensives than normotensives and, among hypertensives, higher in the subgroup with elevated microalbuminuria. In hypertensives, we found a weak but significant correlation between SLC and microalbuminuria, independent of insulin or ISI. The prevalence of high value of SLC (> or =0.383 mmol x L-1 x h-1) was significantly lower in hypertensives with normal rather than abnormal urinary albumin excretion. Our results indicate that in nondiabetic hypertensive whites, higher microalbuminuria is accompanied by signs of insulin resistance; moreover, a link exists between SLC and microalbuminuria, both predictive of aggressive complications of hypertension.
authors.affiliation: Internal Medicine and Hypertension Centre, University of Palermo, Italy. androp@unipa.it
authors.forename: G
authors.initials: G
authors.lastname: Andronico
authors.forename: L
authors.initials: L
authors.lastname: Ferrara
authors.forename: M
authors.initials: M
authors.lastname: Mangano
authors.forename: G
authors.initials: G
authors.lastname: Mulè
authors.forename: G
authors.initials: G
authors.lastname: Cerasola
mesh_terms: D000419:Albuminuria / Q000150:complications*; D001693:Biological Transport, Active; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000150:complications / Q000378:metabolism*; D007328:Insulin / Q000097:blood*; D007333:Insulin Resistance; D008094:Lithium / Q000378:metabolism*; D008297:Male; D012964:Sodium / Q000378:metabolism*
chemical_list: D007328:Insulin; D008094:Lithium; D012964:Sodium